Moreover, the low nasal congestion (3.7%) and the rare rhinorrhea in COVID-19 cohorts [78] supports the idea that there is neurological dysfunction in the olfactory bulbs, suggesting that NRP1 could be a possible candidate for the physiopathology mechanism of the anosmia in COVID-19. This evidence concerns the gene NRP1 and COVID-19.